Jonathan Zung, Ph.D., has served as Chief Development Officer since January 2021. Prior to joining Evelo, Jonathan was President of Sponsor and CRO Programs at WCG Clinical. Prior to WCG Clinical, he served as the Group President of Clinical Development and Commercialization Services at Covance Drug Development, where he led a global organization of over 8,000 employees in 60 countries spanning all phases of development (Phase 1-4), along with global market access services. Jonathan has also held leadership roles of increasing responsibility at UCB, Bristol Myers Squibb, and Pfizer. Jonathan received his Ph.D. in analytical chemistry from Emory University and a B.S. in chemistry from the Florida Institute of Technology.
Jonathan Zung, Ph.D.
Chief Development Officer